RI-MUHC teams received $10.9 million in project funding

Source: RI-MUHC and CIHR

Researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) will lead 15 new projects designed to accelerate discoveries of benefit to human health, thanks to the Canadian Institutes of Health Research (CIHR) Spring 2023 Project Grants Competition. The RI-MUHC teams received over $16.5 million in project funding.

Across Canada, the competition has approved 381 research grants for a total investment of approximately $325 million. In addition, 62 priority announcement grants were approved for a total of $7.2 million, along with 12 bridge grants totalling $1.2 million and five supplemental prizes totalling $250,000.

The CIHR Project Grant program is designed to capture ideas with the greatest potential to advance health-related fundamental or applied knowledge, health research, health care, health systems, and/or health outcomes.

“We are extremely proud of the success of RI-MUHC grant recipients and their teams and confident that their projects funded in this competition will impact Canadian health care across the lifespan in so many important spheres,” says Dr. Rhian Touyz, Executive Director and Chief Scientific Officer, RI-MUHC. “These results testify to the dedication and excellence of the RI-MUHC research community.”

Congratulations to RI-MUHC grant recipients and their teams!

PROJECT GRANTS

• Geneviève Bernard
  RNA polymerase III-related leukodystrophy: Understanding disease pathogenesis and developing novel therapeutic approaches using murine models
• Julia Burnier
  Modelling cancer cell-derived extracellular vesicles using synthetic nanoparticles
• Jonathon Campbell, James C. Johnston, Sarah K. Brode
  A Key Step to Eliminating Tuberculosis in Canada: Informing the Implementation and Scale-up of Tuberculosis Preventive Treatment
• Julio F. Fiore Jr., Justin Rivard, May Lynn Quan, Jad Abou Khalil, Christine Desbiens, Emily G. McDonald, Liane S. Feldman, Ipshita Prakash, Stephanie M. Wong, Sarkis H. Meterissian, Allison Maciver, Lisa Findlay-Shirras
  Comparative effectiveness of opioid versus opioid-free post-discharge analgesia after outpatient breast surgery: A randomized controlled trial
• Catherine Goudie
  Leveraging precision medicine and eHealth to predict cancer predisposition syndromes in children: A Canadian initiative to redress global health disparities in cancer genetics
• Ariane Marelli
  Exposure to Low Dose Ionizing Radiation In Adult Patients with Congenital Heart Disease - A Time Series Analysis Assessing the Past and Projecting the Future
• James G. Martin
  Understanding the Mechanistic Basis of Irritant-Induced Airway Dysfunction
• Thomas Mavrakanas, William Beaubien-Souligny
  Identification, description, and prognostic significance of latent classes based on hemodynamic indicators for patients on maintenance hemodialysis.
• Suzanne N. Morin, William D.Leslie, Lisa M. Lix
  Effectiveness and Safety of Long-term Antiresorptive Treatment for Osteoporosis in Canada: Improving Shared Decision Making
• Dan Poenaru, Ariane Marelli
  A voice to the voiceless: Longitudinal patient-reported outcomes, experiences, social determinants of health and health services utilization after major neonatal surgery
• Alain Ptito
  Imaging biomarkers for early identification of mTBI patients at risk for persistent post-concussive symptoms.
• Shafaat A. Rabbani
  Role of methyl-CpG-binding domain protein 2 (Mbd2) in breast cancer development, progression and metastasis
• Jonathan D. Spicer
  Role of the circadian rhythm in the regulation of the tumor microenvironment of non-small cell cancer
• Donald J. van Meyel
  Dual-function glutamate transporter/chloride channels in brain physiology and neurological diseases.

PRIORITY ANNOUNCEMENTS

HIV/AIDS and STBBI

• Nadine Kronfli, Frederick L. Altice
  Enhancing uptake of needle and syringe programs in Canadian federal prisons

Learn more on the Canadian Institutes of Health Research (CIHR) website

—Published August 25, 2023